Neuronetics amended its report solely to refile a legal opinion and consent that superseded and replaced the originals. The underlying offering covered 18,750,000 common shares at $1.60 per share.
STIM · Neuronetics, Inc. · Documents
Substantial doubt about the company's ability to continue as a going concern.
“Therefore, substantial doubt exists about the Company’s ability to continue as a going concern. However, at this time, these actions do not fully mitigate the risk related to compliance with the revenue covenant for the March 31, 2027 period.”View the 10-Q filed Nov 4, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Neuronetics, Inc. priced an offering of 18,750,000 common shares at $1.60 per share, expecting approximately $27.7 million in net proceeds. It will use part of the proceeds to repay Perceptive Credit Holdings IV, LP term loans and for general corporate purposes.
Neuronetics, Inc. entered Amendment No. 6 on November 5, 2026, modifying revenue covenants, conditional on a prepayment of no less than $15,000,000. Unless conditions are satisfied or waived by November 30, 2026, the amendment automatically terminates.
Neuronetics reported third-quarter revenue of $42.0 million, up 13%, and a $1.6 million net loss, but projected March 31, 2027 trailing revenue below its covenant minimum creates substantial going-concern doubt.
Neuronetics reported third-quarter 2026 revenue of $42.0 million, up 12.5%, and adjusted EBITDA of $1.9 million versus $(4.7) million last year. Net loss was $1.6 million, and full-year revenue guidance remained $160 million and $164 million.